. . .
Interstitial lung diseases
Pulmonary vascular diseases
Respiratory infections
General respiratory patient care
Pulmonary function testing
Pulmonary rehabilitation
Statements and technical standards
ERS statement on long COVID-19 follow-up
COVID
Aims : to identify optimal strategies for follow-up care that will positively impact the COVID-19 patient’s quality of life who frequently experience symptom burden postacute infection or posthospitalisation; to review the consequences on quality of life, symptom burden, disability and home care follow-up; to answer eight clinical questions: 1. Are there features of the acute disease that predict long-term consequences? 2. Which follow-up strategies relate to thromboembolic events? 3. Which follow-up strategies relate to pulmonary physiology? 4. Which follow-up strategies relate to imaging? 5. Which follow-up strategies relate to infection control? 6. Which follow-up strategies relate to cognitive, psychological and quality-of-life consequences? 7. Which follow-up strategies relate to disability? 8. Which follow-up strategies relate to home care follow-up (telemedicine/telerehabilitation)?
Target audience :
Adult pulmonologist/Clinician,
Clinical researcher,
General practitioner,
Medical Student,
Nurse,
Respiratory critical care physician,
Paediatrician,
Pathologist,
Patient,
Physician in Pulmonary Training,
Radiologist,
Respiratory physiotherapist,
Respiratory therapist
Methods :
General respiratory patient care,
Pulmonary function testing,
Pulmonary rehabilitation
00:00
ERS statement on long COVID-19 follow-up
A. Spanevello
(Milano, Italy)
COI
1
11
. . .